2-Aminoethyl Methyl Sulfon Hydrochloride CAS 104458-24-4 Pite> 99.0% (HPLC)

Deskripsyon kout:

2-Aminoethyl Methyl Sulfon Hydrochloride

CAS: 104458-24-4

Pite:> 99.0% (HPLC)

Aparans: poud blan oswa blan

Entèmedyè nan Lapatinib / Lapatinib Ditosylate Monohydrate

Kontakte: Dr Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Voye imèl ba nou

Pwodwi detay

Pwodwi ki gen rapò

Tags pwodwi

Lapatinib Entèmedyè:

Baz Lapatinib	CAS 231277-92-2
Lapatinib ditosylate monoidrat	CAS 388082-78-8
Methanesulfinate sodyòm	CAS 20277-69-4
3-Chloro-4-(3-Fluorobenzyloxy)anilin	CAS 202197-26-0
2-Aminoethyl Methyl Sulfon Hydrochloride	CAS 104458-24-4
4-Chloro-6-Iodoquinazoline	CAS 98556-31-1
6-Iodo-4-Hydroxyquinazoline	CAS 16064-08-7
5-Formil-2-furanboronik asid	CAS 27329-70-0
5-[4-[3-Chloro-4-(3-Fluorobenzyloxy)anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde	CAS 231278-84-5

Pwopriyete chimik:

Non Chimik	2-Aminoethyl Methyl Sulfon Hydrochloride
Sinonim	2-Aminoethylmethylsulfone Hydrochloride;2-(Methylsulfonyl) etanamin Hydrochloride;2-(Methylsulfonyl) Ethylamine HCl;2-Aminoethylmethyl Sulfon HCl;Lapatinib Entèmedyè 1
Nimewo CAS	104458-24-4
Estati Stock	Nan Stock, Pwodiksyon Echèl Jiska Tòn
Fòmil molekilè	C3H9NO2S·HCl
Pwa molekilè	159,63
Pwen k ap fonn	165.0 a 172.0 ℃
Estabilite	Igroskopik
Solibilite	Soluble nan metanol
Egzanp	Disponib
Orijin	Shanghai, Lachin
Mak	Ruifu Chimik

Espesifikasyon:

Atik	Espesifikasyon
Aparans	Poud blan oswa blan
Pite / Metòd analiz	>99.0% (HPLC)
Pwen k ap fonn	165.0 ~ 172.0 ℃
Pèt sou siye	<1.00%
Rezid sou ignisyon	<0.50%
Enpurte total	<1.00%
Metal lou (tankou Pb)	<20ppm
Tès Creole	Enterprise Standard
Itilizasyon	Entèmedyè API (CAS 388082-77-7)

Pake & Depo:

Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an

Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite

Avantaj:

FAQ:

104458-24-4 - Aplikasyon:

2-Aminoethyl Methyl Sulfone Hydrochloride (CAS: 104458-24-4) se yon entèmedyè nan API (CAS: 388082-77-7).(CAS: 388082-77-7) se yon nouvo dwòg ki vize pou tretman kansè nan tete devlope pa GlaxoSmithKline, ki te apwouve pou maketing pa US Food and Drug Administration nan dat 13 mas 2007. Endikasyon yo apwouve kounye a se mastokarcinom avanse trete. ak (CAS: 388082-77-7) ak Capecitabine oswa kansè nan tete metastatik, ak pasyan kansè nan tete yo dwe trete an premye nan lòt dwòg premye klas.Non komèsyal li se Tykerb nan Etazini.Nan dat 14 desanm 2007, Ajans Medikaman Ewopeyen an (EMEA) te apwouve pou maketing an Ewòp, ak non komèsyal la se Tyverb.Terapi molekilè vize kansè nan tete se tretman pou onkojèn ki gen rapò ak ensidan ak devlopman kansè nan tete, ak pou pwodwi ekspresyon ki gen rapò li yo.Medikaman molekilè ki vize kontwole chanjman ekspresyon jèn nan selil la nan bloke transdiksyon siyal selil timè oswa selil ki gen rapò, kidonk anpeche oswa touye selil timè yo.